Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital

被引:47
|
作者
O'Sullivan, JM
Norman, AR
Cook, GJ
Fisher, C
Dearnaley, DP
机构
[1] Royal Marsden Hosp, Royal Marsden NHS Trust, Inst Canc Res, Acad Unit Radiotherapy & Clin Oncol, Sutton SM2 5PT, Surrey, England
[2] Royal Marsden Hosp, Inst Canc Res, Dept Comp & Informat, Sutton SM2 5PT, Surrey, England
[3] Royal Marsden Hosp, Inst Canc Res, Dept Nucl Med, Sutton SM2 5PT, Surrey, England
[4] Royal Marsden Hosp, Inst Canc Res, Dept Histopathol, Sutton SM2 5PT, Surrey, England
关键词
radionuclide imaging; prostatic neoplasms; bone metastases; Gleason scoring;
D O I
10.1046/j.1464-410X.2003.04480.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To determine if it is possible to exclude staging bone scans in a greater proportion of patients if more consideration is given to T stage and Gleason score, as recent guidelines from the National Institute of Clinical Excellence state that routine staging bone scans for prostate cancer are unnecessary in patients with a prostate specific antigen level (PSA) of < 10 ng/mL and Gleason scores of < 8. We identified a cohort of consecutive patients with untreated prostate cancer who had a staging isotope bone scan between 1 January 1995 and 31 December 2000, who were not on hormone therapy, who had their PSA estimated within 30 days of the scan, and who had histologically confirmed prostate cancer on biopsy reviewed at the Royal Marsden. Data were analysed according to Gleason score, major Gleason grade, clinical T-stage and PSA level. In all, 420 patients were identified who fulfilled the criteria for inclusion; 67 scans (16%, 95% confidence interval, CI, 13-20%) were positive. Of the 187 scans taken in patients with a PSA level of less than or equal to 20 ng/mL, stage < T4 and Gleason < 8 (with major Gleason grade < 4), two (1%, 0.3-4%) were reported as positive, giving a negative predictive value of 99% (95% CI 98.5-99.5%) for these criteria for avoiding the need for staging bone scans. In 116 patients (28%) with Gleason score 7, of whom 28 (24%) had positive scans, there was a statistically significant association between positive scans and a major Gleason pattern of 4 compared with 3. Isotope bone scans are an unnecessary part of staging of prostate cancer if the PSA level is less than or equal to 20 ng/mL, stage < T4 and Gleason score < 8, and should be omitted unless the major Gleason pattern is 4. The present results suggest that by considering the Gleason score and T stage, a larger proportion of patients with prostate cancer than previously thought could avoid a staging bone scan.
引用
收藏
页码:685 / 689
页数:5
相关论文
共 50 条
  • [21] Do Royal Marsden Hospital (RMH) and MD Anderson Cancer Center (MDACC) prognostic scoring systems predict survival in patients with bone sarcoma?
    Alselwi, W.
    Azam, F.
    Latif, M. F.
    Osman, I. A. E-H.
    Taha, W. A. H.
    Bawazir, K.
    Farooq, A.
    Bukhari, N.
    Ibnshamsah, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] Hurthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003
    Mills, S. C.
    Haq, M.
    Smellie, W. J. B.
    Harmer, C.
    EJSO, 2009, 35 (03): : 230 - 234
  • [23] Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital
    Li, Su
    Sharma, Bhupinder
    Yusuf, Siraj
    Michalarea, Vasiliki
    Gleeson, Mary
    Hickmott, Laura
    Wotherspoon, Andrew
    Attygalle, Ayoma D.
    Vroobel, Katherine
    O'Connor, Simon
    Du, Yong
    Kuhnl, Andrea
    Iyengar, Sunil
    El-Sharkawi, Dima
    Chau, Ian
    Cunningham, David
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (01): : 48 - 54
  • [24] Changing the Referral Criteria for Bone Scan in Newly Diagnosed Prostate Cancer Patients in a District General Hospital
    McArthur, C.
    McLaughlin, G.
    Meddings, B.
    SCOTTISH MEDICAL JOURNAL, 2010, 55 (01) : 50 - 50
  • [25] A RETROSPECTIVE STUDY OF PREDICTORS OF BONE METASTASIS IN PROSTATE CANCER
    Christopher, C.
    Poh, K.
    Muhilan, P.
    Azad, H.
    Goh, E.
    Praveen, S.
    Tan, G.
    Badrulhisham, B.
    Zulkifli, M.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 362 - 362
  • [26] Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis
    Sahin, Taha Koray
    Rizzo, Alessandro
    Aksoy, Sercan
    Guven, Deniz Can
    CANCERS, 2024, 16 (10)
  • [27] A study of factors determining outcome of patients receiving third line chemotherapy for metastatic breast cancer: The Royal Marsden Hospital experience.
    Kuciejewska, A.
    Banerji, U.
    Walsh, G.
    Ashley, S.
    O'Brien, M.
    Johnston, S.
    Smith, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 42S - 42S
  • [28] Retrospective Analysis of Survival Outcomes for Patients Receiving Umbilical Cord Blood Transplants at the Royal Marsden Hospital Between 2007 and 2017
    Easdale, Sandra
    Anthias, Chloe Anthias
    Nicholson, Emma
    Brennan, Joy
    Mulligan, Maria
    Potter, Mike
    Ethell, Mark
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 413 - 414
  • [29] ORCHIDECTOMY FOR CLINICAL STAGE-I TESTICULAR CANCER - PROGRESS REPORT OF THE ROYAL-MARSDEN-HOSPITAL STUDY
    PECKHAM, MJ
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1985, 78 : 41 - 42
  • [30] The Value of Bone Scans to Predict Survival Time in Patients with Diagnosed Prostate Cancer
    Marangoz, E.
    Yuksel, D.
    Yaylali, O.
    Kirac, F. S.
    Eskicorapci, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S470 - S470